Repare Therapeutics Inc. - RPTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | — | U | D | 548,938.0 | — | — | 0.0 | View | |
| Jan 30, 2026 | — | U | D | 4,308,573.0 | — | — | 0.0 | View | |
| Jan 30, 2026 | — | U | D | 5,309,432.0 | — | — | 0.0 | View | |
| Jan 28, 2026 | — | D | D | 37,941.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | — | D | D | 8,000.0 | — | — | 0.0 | View | |
| Jan 28, 2026 | — | D | D | 4,000.0 | — | — | 0.0 | View | |
| Jan 28, 2026 | — | D | D | 7,500.0 | — | — | 0.0 | View | |
| Jan 28, 2026 | EVP, CHIEF FINANCIAL OFFICER | D | D | 325,800.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | EVP, CHIEF FINANCIAL OFFICER | D | D | 500,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | EVP, CHIEF FINANCIAL OFFICER | D | D | 85,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | EVP, CHIEF FINANCIAL OFFICER | D | D | 200,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | EVP, CHIEF FINANCIAL OFFICER | D | D | 56,786.0 | — | — | 0.0 | View | |
| Jan 28, 2026 | SVP, Finance and CAO | D | D | 24,500.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | SVP, Finance and CAO | D | D | 26,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 28, 2026 | SVP, Finance and CAO | D | D | 31,622.0 | — | — | 0.0 | View |